New insights into systemic sclerosis / / edited by Michal Tomcik.
Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic fe...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London, United Kingdom : : IntechOpen,, [2019] ©2019 |
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 online resource (160 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 01062nam a2200313 i 4500 | ||
---|---|---|---|
001 | 993544010404498 | ||
005 | 20221019220821.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 221019s2019 enka ob 000 0 eng d | ||
020 | |a 1-83962-206-7 | ||
020 | |a 1-83962-205-9 | ||
035 | |a (CKB)4920000000094428 | ||
035 | |a (NjHacI)994920000000094428 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/54593 | ||
035 | |a (EXLCZ)994920000000094428 | ||
040 | |a NjHacI |b eng |e rda |c NjHacl | ||
041 | 0 | |a eng | |
050 | 4 | |a RC924.5.S34 |b .N49 2019 | |
082 | 0 | 4 | |a 616.544 |2 23 |
100 | 1 | |a Michal Tomcik |4 auth | |
245 | 0 | 0 | |a New insights into systemic sclerosis / |c edited by Michal Tomcik. |
260 | |b IntechOpen |c 2019 | ||
264 | 1 | |a London, United Kingdom : |b IntechOpen, |c [2019] | |
264 | 4 | |c ©2019 | |
300 | |a 1 online resource (160 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
588 | |a Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022). | ||
504 | |a Includes bibliographical references. | ||
520 | |a Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma. | ||
546 | |a English | ||
650 | 0 | |a Systemic scleroderma. | |
653 | |a Medicine | ||
653 | |a Immunopathology | ||
653 | |a Immunology | ||
653 | |a Allergology and Rheumatology | ||
653 | |a Health Sciences | ||
776 | |z 1-83962-204-0 | ||
700 | 1 | |a Tomcik, Michal , |e editor. | |
906 | |a BOOK | ||
ADM | |b 2023-02-22 21:26:42 Europe/Vienna |f system |c marc21 |a 2019-11-10 04:18:40 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351662700004498&Force_direct=true |Z 5351662700004498 |b Available |8 5351662700004498 |